col3

Chemically modified tetracyclines (CMTs) can inhibit MMPs, but lack antimicrobial activity. Nonantimicrobial derivative of tetracycline called incyclinide (COL-3, CMT-3). Incyclinide (CMT-3) has been shown to experimentally suppress prostate cancer, colon adenocarcinoma and melanoma invasiveness in cell culture and to inhibit tumor growth and metastasis.

PEG300 (Polyethylene glycol 300) is a polymer formed from repeating units of ethylene glycol that is water soluble, low immunogenicity, and biocompatible. PEG300 is a neutral polymer with a molecular weight of 300.

PEG35000 is a polyethylene glycol with a molecular weight of 35,000, used as a carrier material and modifier in drug delivery systems.

PEG 3350 (Polyethylene glycol 3350) is a PEG polymer with a molecular weight of 3350. It serves as a laxative, thickening agent and solvent, and is extensively utilised in related research within the life sciences sector.

Polyethylene glycol (PEG) is approved by the FDA for use as a carrier or matrix in foods, cosmetics, and pharmaceuticals, including injectable, topical, rectal, and nasal formulations. PEG exhibits minimal toxicity and can be fully excreted from the body via the kidneys (for PEG <30 kDa) or feces (for PEG >20 kDa). It is non-immunogenic, and antibodies to PEG only develop in rabbits when PEG is combined with highly immunogenic proteins.

Chloramphenicol 3-O-β-D-glucuronide is a biochemical reagent utilized in glycobiology research. Glycobiology focuses on the structure, synthesis, biology, and evolution of sugars, involving carbohydrate chemistry, glycans' formation and degradation enzymology, protein-glycan recognition, and the role of glycans in biological systems. This field is closely related to fundamental research, biomedicine, and biotechnology.